We are live on ! Find out more
GW

GW & Wade Portfolio holdings

AUM $3.08B
1-Year Est. Return 18.99%
This Fund
S&P 500
This Quarter Est. Return
+3.4%
1 Year Est. Return
+18.99%
3 Year Est. Return
+32.19%
5 Year Est. Return
+95.75%
10 Year Est. Return
+162.41%
AUM
$1.1B
AUM Growth
+$42.2M
Cap. Flow
+$12.2M
Cap. Flow %
1.11%
Top 10 Hldgs %
33.6%
Holding
243
New
14
Increased
122
Reduced
64
Closed
9

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$10.2M
2
MDT icon
Medtronic
MDT
+$8.87M
3
SO icon
Southern Company
SO
+$5.12M
4
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$3.51M
5
WMT icon
Walmart Inc
WMT
+$2.33M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$10.3M
2
CCI icon
Crown Castle
CCI
+$8.95M
3
AMGN icon
Amgen
AMGN
+$4.4M
4
VOD icon
Vodafone
VOD
+$2.5M
5
TRV icon
Travelers Companies
TRV
+$2.08M

Sector Composition

Rank Sector Weight
1 Technology 11.55%
2 Industrials 8.04%
3 Energy 7.64%
4 Consumer Staples 7.19%
5 Healthcare 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTN
126
DELISTED
Raytheon Company
RTN
$724K 0.07%
4,166
+155
+4% +$27.9K
LLL
127
DELISTED
L3 Technologies, Inc.
LLL
$714K 0.06%
2,912
+7
+0.2% +$1.64K
CHD icon
128
Church & Dwight Co
CHD
$23.1B
$703K 0.06%
9,620
+17
+0.2% +$1.26K
C icon
129
Citigroup
C
$216B
$694K 0.06%
9,913
-188
-2% -$12.6K
SPGI icon
130
S&P Global
SPGI
$133B
$694K 0.06%
3,045
-166
-5% -$36.3K
DOL icon
131
WisdomTree True Developed International Fund
DOL
$803M
$687K 0.06%
14,576
-149
-1% -$6.97K
MA icon
132
Mastercard
MA
$483B
$684K 0.06%
2,585
+10
+0.4% +$2.5K
LRCX icon
133
Lam Research
LRCX
$385B
$682K 0.06%
36,320
+400
+1% +$7.59K
ABBV icon
134
AbbVie
ABBV
$447B
$681K 0.06%
9,361
-1,535
-14% -$121K
NKE icon
135
Nike
NKE
$64.2B
$676K 0.06%
8,055
+3,317
+70% +$279K
ORCL icon
136
Oracle
ORCL
$352B
$672K 0.06%
11,799
-1,457
-11% -$78.8K
ZTS icon
137
Zoetis
ZTS
$31.8B
$658K 0.06%
5,800
+6
+0.1% +$628
AIVL icon
138
WisdomTree US AI Enhanced Value Fund
AIVL
$425M
$649K 0.06%
7,569
– –
INTU icon
139
Intuit
INTU
$80.5B
$644K 0.06%
2,464
+3
+0.1% +$762
GILD icon
140
Gilead Sciences
GILD
$166B
$574K 0.05%
8,490
-85
-1% -$5.59K
VTI icon
141
Vanguard Total Stock Market ETF
VTI
$657B
$557K 0.05%
3,709
-1,592
-30% -$234K
COP icon
142
ConocoPhillips
COP
$141B
$550K 0.05%
9,020
-27
-0.3% -$1.68K
AMLP icon
143
Alerian MLP ETF
AMLP
$12.8B
$525K 0.05%
10,650
– –
RPD icon
144
Rapid7
RPD
$810M
$517K 0.05%
8,937
– –
GIS icon
145
General Mills
GIS
$20.1B
$512K 0.05%
9,754
– –
AMT icon
146
American Tower
AMT
$77.7B
$503K 0.05%
2,459
+1
+0% +$201
CMCSA icon
147
Comcast
CMCSA
$85.3B
$491K 0.04%
11,608
-978
-8% -$41.3K
FIS icon
148
Fidelity National Information Services
FIS
$21.8B
$490K 0.04%
3,993
-25
-0.6% -$2.94K
EVRG icon
149
Evergy
EVRG
$19.7B
$484K 0.04%
8,044
– –
IAU icon
150
iShares Gold Trust
IAU
$62.4B
$457K 0.04%
16,944
+6,599
+64% +$165K
4 5
6
7 8

Similar funds

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

GW & Wade's Q2 2019 Portfolio in Review

As of Q2 2019, GW & Wade held 243 positions worth $1.1B, up 4% from $1.06B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

GW & Wade's Q2 2019 filing shows 14 new, 122 increased, 64 reduced and 9 closed positions. Its largest new stake was GSK: 15,322 shares worth $767K. The largest sale was 3M, an estimated $10.3M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Industrials and Energy.

  • GW & Wade's largest Q2 2019 buy was GSK: 15,322 shares worth $767K.
  • GW & Wade added most to Pfizer in Q2 2019, an estimated $10.2M increase.
  • GW & Wade's biggest Q2 2019 reduction was 3M, cutting an estimated $10.3M.
  • GW & Wade fully exited Crown Castle in Q2 2019, selling an estimated $8.95M.
  • GW & Wade's ten largest holdings make up 34% of its $1.1B portfolio in Q2 2019.
  • GW & Wade opened 14 new positions and closed 9 in Q2 2019.
  • GW & Wade's portfolio value rose 4% quarter-over-quarter to $1.1B.

Based on GW & Wade's 13F filing for Q2 2019, filed 12 Aug 2019.